ArticleAsian Pacific journal of cancer prevention : APJCP2025
Comparing the Therapeutic Efficacy of Curcuma Caesia Roxb Over Curcuma Longa in Managing Oral Submucous Fibrosis: A Non-Randomized Clinical Trial.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine and compare the therapeutic efficacy of Curcuma caesia Roxb over Curcuma Longa in managing Oral Submucous Fibrosis (OSMF). MATERIALS AND
methodsA clinical trial was conducted on 51 patients diagnosed with oral submucous fibrosis, who were equally divided into two groups. The first group received a treatment of powdered Curcuma caesia Roxb mixed with honey in an equal ratio. In contrast, the second group received powdered Curcuma longa mixed with honey in a similar ratio. Both groups were instructed to apply the mixture thrice daily for three months. Additionally, a control group received a placebo, and all patients were advised to continue physiotherapeutic mouth-opening exercises for three months. The parameters evaluated included burning sensation, cheek flexibility, mouth opening, and tongue protrusion.
resultsStatistically significant results were observed after 3 months (P < 0.001). Group A showed more symptomatic improvement than Group B. Group A experienced a significant reduction in burning sensation and increased mouth opening, while Group B showed significant improvement in cheek flexibility. The mean percentage increase in mouth opening was significantly greater in Group A compared to Group B, but VAS scores for burning sensation did not show marked differences. P-value was statistically significant in both cases to show promising results.
conclusionThe study shows that Group A patients had reduced burning sensation, improved tongue protrusion, and increased mouth opening, while Group B had slightly better cheek flexibility. Curcuma caesia roxib improved clinical parameters like burning, tongue flexibility, and mouth opening. The study concludes that combination therapy can manage complex conditions like Oral Submucous Fibrosis effectively. Larger-scale studies with bigger sample sizes are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.